Comparative Tolerability of Treatments for Inflammatory Bowel Disease

Author： Stein R.B.  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.23, Iss.5, 2000-11, pp. : 429-448

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of Treatments for Inflammatory Bowel Disease

By Bodger Keith  

PharmacoEconomics, Vol. 29, Iss. 5, 2011-05 ,pp. : 387-401

Adis International

Access to resources Recommend Favorite

Inflammatory Bowel Disease in the Elderly

By >   Pardi Darrell S.  

Drugs & Aging, Vol. 27, Iss. 8, 2010-08 ,pp. : 617-624

Adis International

Access to resources Recommend Favorite

Macrophages in Inflammatory Bowel Disease

By  

Current Drug Targets. Inflammation & Allergy, Vol. 2, Iss. 2, 2003-06 ,pp. : 155-160

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics and Inflammatory Bowel Disease

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 6, Iss. 3, 2008-09 ,pp. : 201-224

Bentham Science Publishers

Access to resources Recommend Favorite

Comparative Efficacy and Tolerability of Drug Treatments for Bipolar Disorder

By Strakowski S.M.   Del Bello M.P.   Adler C.M.  

CNS Drugs, Vol. 15, Iss. 9, 2001-01 ,pp. : 701-718

Adis International

Access to resources Recommend Favorite